INDV · Healthcare · $4.5B
$35.39-1.30%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 61 Drug Manufacturers - Specialty & Generic peers
Quarterly Revenue Growth
“SUBLOCADE(서브로케이드)라는 마약성 진통제 중독 치료 주사제가 이번 분기에 정말 잘 팔렸어요.”
In the company's words · 2026 1분기 earnings call